Board Members

Dana Bryson
Dana Bryson
Dr Stephen P. Hunger
Dr Stephen P. Hunger
Dr Tristan Flatt
Dr Tristan Flatt

Dana Bryson brings over 25 years of experience in public, business enterprise, and non-profit sectors to increase social impact investment and grow community capacity.

Ms. Bryson has also been a Cabinet-level appointee for two US Mayors, (Jerry Brown and Anthony Williams) and was a senior appointee for Denver Mayor John Hickenlooper. In these roles, she served Mayoral Chief of Staff or had oversight for City Operations.

Dr. Hunger specializes in research and treatment regarding children, adolescents and young adults with acute lymphoblastic leukemia (ALL).  He has authored more than 225 peer-reviewed manuscripts.  He was the Vice-Chairman (2002-2007) and Chairman (2008-2015) of the Children’s Oncology Group (COG) ALL Disease Committee.  In these roles, he has been responsible for oversight of the design and conduct of clinical trials and linked translational research studies that enroll over 2000 children with ALL each year, including more than 70% of US children and adolescents diagnosed with ALL.  Dr. Hunger leads the COG ALL TARGET Project, that has conducted comprehensive studies of the genetic features of childhood ALL and revolutionized understanding of the genomic landscape of pediatric ALL.

Tristan is a pediatric hematologist/oncologist at Children’s Mercy Hospital in Kansas City, MO.  He is the director of their Spanish-speaking clinic and research program.   He has a long time commitment to Mexican culture as he was an anthropologist and worked in Mexico for several years prior to attending medical school.  His area of research is acute lymphoblastic leukemia among Hispanic children with a specific focus on novel genes that portend poor outcome as well as possible predisposition genes.  He has two grant-funded studies in Mexico and he mentors and sponsors Mexican fellows and residents regularly at the hospital.

E. Martin Cochran
E. Martin Cochran
Gordon Morrison, Secretary
Gordon Morrison, Secretary
Kathleen Paisley
Kathleen Paisley

Marty Cochran is a licensed attorney with over sixteen years’ experience in dealing with the legal aspects of business, private equity, real estate and finance transactions.  Mr. Cochran attended college at the University of Georgia in Athens, Georgia and Missouri State University in Springfield, Missouri where he received a Bachelor’s Degree in Finance from the Honor’s College.  Mr. Cochran then attended law school at the University of Missouri in Columbia, Missouri where he received a Juris Doctorate.  Mr. Cochran went on to earn an LL.M. (Master’s in Law) in International Taxation and Finance from Regent University in Virginia Beach, Virginia.

Gordon obtained an Honours Degree in Civil Engineering from the University of Edinburgh prior to joining the Family Construction business which was built up to become a UK wide and international construction, development and support services business.  Morrison Construction Group was sold in 2000 and Gordon transferred his attention to farming, property and charity work.

  Kathleen Paisley has worked as a Physician Assistant at Memorial Sloan Kettering Cancer Center in New York City for over 20 years. She works in the Department of Surgery on the Gastric Mixed Tumor Service specializing in melanoma, Merkel cell carcinoma, sarcoma, gastric, pancreatic and adrenal tumors. In addition, she also runs the GMT Survivorship Clinic maintaining extended care for cancer patients. Kathleen did her undergraduate studies at the University of Virginia and her Physician Assistant studies at Cornell University Medical School.  She lives in New York with her husband and four children. 

Louis Efron
Louis Efron
Patricia McCall
Patricia McCall
Patrick Weinberg, Treasurer
Patrick Weinberg, Treasurer

Louis Efron is a globally recognized thought leader, speaker, writer, and Fortune 200 HR Executive. He is the author of How to Find a Job, Career and Life You Love and Purpose Meets Execution and two upcoming books, Beyond the Ink and the children’s book, What Kind of Bee can I be? He is a contributing writer for Forbes and Huffington Post and the founder of The Voice of Purpose and the charity World Child Cancer USA. His career credits include Head of Global Engagement for Tesla Motors, International VP of HR for JDA Software, VP of HR for the Fortune 300 medical device company, Stryker, Broadway theatre and currently serves as the VP of Teammate Experience for DaVita, a Fortune 200 medical company. He studied Labor Relations at Cornell University, New York State School of Industrial and Labor Relations, and Advanced Leadership at Harvard Business School. He holds a BA from California State University, Fullerton, as well as a BS and JD from Saratoga University School of Law.

Patricia is currently the Executive Director of the Centre for Economic Growth at INSEAD, based in Abu Dhabi. The Centre for Economic Growth focuses on developing policies for regional governments and the private sector in the area of economic growth, education, job creation and youth employment. She is also the Executive Director of the Arab Stabilization Plan, a policy initiative that aims to address the youth unemployment crisis in the MENA region through infrastructure development. She was previously the Regional Director for Duke University where she was responsible for the University’s activities in the region. She has worked on investment climate and economic reform for the United Nations in Afghanistan as well as the World Bank in Egypt and Jordan.

Patrick Weinberg is Treasurer and Director of World Child Cancer USA and an energetic global finance executive with significant experience building and leading international operations, managing startups and turnarounds.

Patrick is currently Chief Financial Officer and member of the global executive team at Addivant, one of the world’s leaders in specialty additives for the polymer and rubber industry.

Richard Volpe
Richard Volpe
Scott Howard, MD, MSc, President
Scott Howard, MD, MSc, President
Serge Rogasik
Serge Rogasik

Richard Volpe, Managing Director, is Global Head of Rates at Nomura, Asia’s global investment bank. Richard oversees flow and structured rates for all regions. In addition to his role as Global Head of Rates, Richard is also Head of Liquid Products and has direct responsibility for Agency Mortgages, Emerging Markets Macro and G10 FX businesses in the Americas. He is a member of the Wholesale Executive Committee (WEC), Global Markets Executive Committee and the Global Markets Americas Management Committee.

Richard joined Nomura in 2015 from Royal Bank of Scotland (RBS) where he was Head of Global USD Rates Trading/Yen Delta based in America. Before joining RBS in 2008, he was at Bear Stearns where he joined in 1993 and was most notably Co-head of US Interest Rate Trading in New York.

Richard graduated from the University of Delaware with a BA in Political Science.

After training in internal medicine, pediatrics, and epidemiology at the University of Tennessee and completing a hematology/oncology fellowship at St. Jude Children’s Research Hospital, Scott worked for 14 years as a faculty member treating children with leukemia and lymphoma and conducting research in oncology supportive care, international oncology, and healthcare informatics. Scott has authored or co-authored 190 scientific papers and 15 book chapters and conducts translational and clinical research with local and international collaborators. After leaving St. Jude in 2014, he founded Resonance, an informatics, consulting, and global health company with a mission to improve care and outcomes in low- and middle-income countries.

Serge has more than 20 years of experience in the biotech and chemical industry, driving growth, innovation and transformative strategies in multiple regions of the world.

Serge grew up in France and started his career in drug-delivery research in Belgium prior to taking various growth-oriented positions in marketing, strategy and business management in large, multinational corporations such as Solvay, General Electric or BASF. Serge joined Addivant as an operating partner in 2013 when SK Capital, a New York City private investment firm, acquired the activity.